JENNIFER JOHNSON: Open Payments
NPI 1750756136 · LOUISA, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$597 in 33 payments from 8 companies in 2025. Trend: 2023 $372 · 2024 $448 · 2025 $597
Food & beverage: $597
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $191 |
| GlaxoSmithKline, LLC. | 12 | $165 |
| Novo Nordisk Inc | 4 | $78 |
| Lilly USA, LLC | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Corcept Therapeutics | 2 | $36 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Abbott Laboratories | 1 | $19 |
Products named: TRELEGY ELLIPTA, QULIPTA, Ozempic, MOUNJARO, AIRSUPRA, Korlym, UBRELVY, INSPIRE.
Industry payments across KY — which companies pay providers there.
